-
公开(公告)号：US07851484B2
公开(公告)日：2010-12-14
申请号：US12058127
申请日：2008-03-28
申请人： Bradley P. Morgan , David J. Morgans, Jr. , Gustave Bergnes , Alex Muci , Scott Collibee , Pu-Ping Lu , Luke W. Ashcraft , William F. Browne, IV , Marc Andrew Garard
发明人： Bradley P. Morgan , David J. Morgans, Jr. , Gustave Bergnes , Alex Muci , Scott Collibee , Pu-Ping Lu , Luke W. Ashcraft , William F. Browne, IV , Marc Andrew Garard
IPC分类号： A61K31/444 , C07D471/02 , A61P21/00
CPC分类号： C07D471/04
摘要： Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of muscle weakness and/or cachexia, as part of a rehabilitation or conditioning exercise regimen, or in the treatment of fraility, post-polio syndrome, obesity, sarcopenia, wasting syndrome, muscle spasm, and other indications.
摘要翻译： 提供某些化学实体以及用于调节骨骼肌球蛋白，骨骼肌动蛋白，骨骼原肌球蛋白，骨骼肌钙蛋白C，骨骼肌钙蛋白I，骨骼肌钙蛋白T和骨骼肌（包括其片段和同种型）以及骨骼肌节的使用方法， 以及用于治疗肌肉无力和/或恶病质的方法，作为康复或调理运动方案的一部分，或用于治疗虚弱，脊髓灰质炎综合征，肥胖症，肌肉减少症，消瘦综合征，肌肉痉挛和其他适应症 。
-
公开(公告)号：US20080242695A1
公开(公告)日：2008-10-02
申请号：US12058127
申请日：2008-03-28
申请人： Bradley P. Morgan , David J. Morgans , Gustave Bergnes , Alex Muci , Scott Collibee , Pu-Ping Lu , Luke W. Ashcraft , William F. Browne , Marc Andrew Garard
发明人： Bradley P. Morgan , David J. Morgans , Gustave Bergnes , Alex Muci , Scott Collibee , Pu-Ping Lu , Luke W. Ashcraft , William F. Browne , Marc Andrew Garard
IPC分类号： A61K31/444 , C07D471/02 , A61P21/00
CPC分类号： C07D471/04
摘要： Provided are certain chemical entities, and methods of use to modulate skeletal myosin, skeletal actin, skeletal tropomyosin, skeletal troponin C, skeletal troponin I, skeletal troponin T, and skeletal muscle, including fragments and isoforms thereof, as well as the skeletal sarcomere, and methods of use in the treatment of muscle weakness and/or cachexia, as part of a rehabilitation or conditioning exercise regimen, or in the treatment of fraility, post-polio syndrome, obesity, sarcopenia, wasting syndrome, muscle spasm, and other indications.
摘要翻译： 提供某些化学实体以及用于调节骨骼肌球蛋白，骨骼肌动蛋白，骨骼原肌球蛋白，骨骼肌钙蛋白C，骨骼肌钙蛋白I，骨骼肌钙蛋白T和骨骼肌（包括其片段和同种型）以及骨骼肌节的使用方法， 以及用于治疗肌肉无力和/或恶病质的方法，作为康复或调理运动方案的一部分，或用于治疗虚弱，脊髓灰质炎综合征，肥胖症，肌肉减少症，消瘦综合征，肌肉痉挛和其他适应症 。
-
3.发明申请公开(公告)号：US20140330011A1
公开(公告)日：2014-11-06
申请号：US14270566
申请日：2014-05-06
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： C07D417/14 , C07D277/82 , C07D417/04 , C07D285/08 , C07D417/12
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，X，Z 1，Z 2，Z 3，Z 4和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
公开(公告)号：US20130060025A1
公开(公告)日：2013-03-07
申请号：US13612715
申请日：2012-09-12
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： C07D285/08 , C07D417/04 , C07D417/06 , C07D417/10 , C07D413/12 , C07D277/82 , C07D413/04 , C07D401/12 , C07D271/113 , C07D249/14 , C07D417/12 , C07D417/14
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，X，Z 1，Z 2，Z 3，Z 4和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
公开(公告)号：US08759380B2
公开(公告)日：2014-06-24
申请号：US13446432
申请日：2012-04-13
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： A61K31/4439 , A61K31/428 , C07D417/12 , C07D277/82
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，X，Z 1，Z 2，Z 3，Z 4和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
公开(公告)号：US09278962B2
公开(公告)日：2016-03-08
申请号：US14270566
申请日：2014-05-06
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： C07D417/12 , C07D417/06 , C07D417/04 , C07D285/08 , C07D401/12 , C07D413/04 , C07D413/12 , C07D417/10 , C07D417/14 , C07D249/14 , C07D271/07 , C07D277/42 , C07D285/135 , A61K31/428 , A61K31/4439 , C07D277/82
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，X，Z 1，Z 2，Z 3，Z 4和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
公开(公告)号：US08686007B2
公开(公告)日：2014-04-01
申请号：US13612715
申请日：2012-09-12
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： A61K31/444 , A61K31/4439 , A61K31/433 , C07D417/04 , C07D417/12 , C07D417/14 , C07D285/135
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
-
公开(公告)号：US20120289698A1
公开(公告)日：2012-11-15
申请号：US13446432
申请日：2012-04-13
申请人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
发明人： Luke W. Ashcraft , Gustave Bergnes , Chihyuan Chuang , Scott Collibee , Pu-Ping Lu , Bradley Morgan , Alex Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang
IPC分类号： C07D417/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D233/88 , C07D413/04 , C07D401/12 , C07D271/113 , C07D249/14 , C07D285/08 , C07D417/14
CPC分类号： C07D401/12 , A61K31/428 , A61K31/4439 , C07D249/14 , C07D271/07 , C07D271/113 , C07D277/42 , C07D277/82 , C07D285/08 , C07D285/135 , C07D413/04 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/10 , C07D417/12 , C07D417/14 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, X, Z1, Z2, Z3, Z4 and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，X，Z 1，Z 2，Z 3，Z 4和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
9.发明申请公开(公告)号：US20150322018A1
公开(公告)日：2015-11-12
申请号：US14594274
申请日：2015-01-12
申请人： Luke W. Ashcraft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R. Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang , Pu-Ping Lu , Antonio Romero
发明人： Luke W. Ashcraft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R. Muci , Xiangping Qian , Jeffrey Warrington , Zhe Yang , Pu-Ping Lu , Antonio Romero
IPC分类号： C07D237/20 , C07D413/04 , C07D401/12 , C07D513/04 , C07D401/14 , C07D417/14 , C07D409/14 , C07D403/04 , C07D401/04
CPC分类号： A61K31/50 , A61K31/16 , A61K31/166 , C07D207/26 , C07D211/76 , C07D213/16 , C07D231/56 , C07D237/06 , C07D237/20 , C07D237/24 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D405/14 , C07D409/14 , C07D411/04 , C07D413/04 , C07D413/14 , C07D417/14 , C07D487/04 , C07D487/10 , C07D513/04 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and m are as defined herein.Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，R 8，R 9，X和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
公开(公告)号：US08969346B2
公开(公告)日：2015-03-03
申请号：US13642207
申请日：2011-04-22
申请人： Luke W. Ashcraft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R. Muci , Xiangping Qian , Jeffrey M Warrington , Zhe Yang , Pu-Ping Lu , Antonio Romero
发明人： Luke W. Ashcraft , Gustave Bergnes , Scott Collibee , Chihyuan Chuang , Jeff Gardina , Bradley P. Morgan , Alex R. Muci , Xiangping Qian , Jeffrey M Warrington , Zhe Yang , Pu-Ping Lu , Antonio Romero
IPC分类号： A61K31/50 , C07D237/20 , C07D401/12 , C07D237/24 , C07D401/04 , C07D403/04 , C07D403/06 , C07D409/14 , C07D411/04 , C07D413/04 , C07D413/14 , C07D417/14 , C07D487/04 , C07D487/10 , C07D513/04 , C07D401/14 , C07D405/14
CPC分类号： A61K31/50 , A61K31/16 , A61K31/166 , C07D207/26 , C07D211/76 , C07D213/16 , C07D231/56 , C07D237/06 , C07D237/20 , C07D237/24 , C07D401/04 , C07D401/12 , C07D401/14 , C07D403/04 , C07D403/06 , C07D405/14 , C07D409/14 , C07D411/04 , C07D413/04 , C07D413/14 , C07D417/14 , C07D487/04 , C07D487/10 , C07D513/04 , Y02A50/465
摘要： Provided are compounds of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X and m are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula I, or a pharmaceutically acceptable salt thereof.Also provided are methods of using a compound of Formula I, or a pharmaceutically acceptable salt thereof.
摘要翻译： 提供式I化合物或其药学上可接受的盐，其中R 1，R 2，R 3，R 4，R 5，R 6，R 7，R 8，R 9，X和m如本文所定义。 还提供了包含式I化合物或其药学上可接受的盐的药学上可接受的组合物。 还提供了使用式I化合物或其药学上可接受的盐的方法。
-
-
-
-
-
-
-
-
-
搜索结果
113 条记录 (耗时 0.051 秒)
